USP13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.979200E-01
Normal-vs-Stage2
6.072200E-01
Normal-vs-Stage3
7.710000E-02
Normal-vs-Stage4
8.066400E-01
Stage1-vs-Stage2
5.293600E-02
Stage1-vs-Stage3
6.592000E-02
Stage1-vs-Stage4
4.338400E-01
Stage2-vs-Stage3
8.176600E-03
Stage2-vs-Stage4
8.008200E-01
Stage3-vs-Stage4
1.452180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.390800E-01
Normal-vs-AfricanAmerican
8.661000E-01
Normal-vs-Asian
3.497800E-01
Caucasian-vs-AfricanAmerican
9.455800E-01
Caucasian-vs-Asian
2.923200E-01
AfricanAmerican-vs-Asian
3.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.228600E-01
Normal-vs-Female
8.058800E-01
Male-vs-Female
8.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.273400E-01
Normal-vs-Age(41-60Yrs)
9.851800E-01
Normal-vs-Age(61-80Yrs)
7.410400E-01
Normal-vs-Age(81-100Yrs)
3.641000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.462800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.993200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.132200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.049000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.063400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.537600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.631600E-01
Normal-vs-Daily Drinker
1.439360E-01
Normal-vs-Weekly Drinker
6.095000E-01
Normal-vs-Occasional Drinker
8.469800E-01
Normal-vs-Social Drinker
8.319000E-01
Non Drinker-vs-Daily Drinker
2.837000E-01
Non Drinker-vs-Weekly Drinker
7.793000E-01
Non Drinker-vs-Occasional Drinker
4.512000E-01
Non Drinker-vs-Social Drinker
1.438370E-01
Daily Drinker-vs-Weekly Drinker
1.720640E-01
Daily Drinker-vs-Occasional Drinker
9.205800E-02
Daily Drinker-vs-Social Drinker
3.465600E-02
Weekly Drinker-vs-Occasional Drinker
6.688800E-01
Weekly Drinker-vs-Social Drinker
2.773800E-01
Occasional Drinker-vs-Social Drinker
4.771800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.805200E-01
Normal-vs-Grade 2
4.843800E-01
Normal-vs-Grade 3
4.814400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.379400E-01
Grade 1-vs-Grade 3
2.574000E-01
Grade 1-vs-Grade 4
4.805200E-01
Grade 2-vs-Grade 3
5.284400E-01
Grade 2-vs-Grade 4
4.843800E-01
Grade 3-vs-Grade 4
4.814400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.625400E-01
Normal-vs-NonDiabetic
8.486600E-01
Diabetic-vs-NonDiabetic
9.536100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.220000E-01
Normal-vs-NoPancreatitis
7.922000E-01
Pancreatitis-vs-NoPancreatitis
6.356200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.694600E-01
Normal-vs-N1
6.208400E-01
N0-vs-N1
2.203800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.066400E-01
Normal-vs-TP53-NonMutant
7.977000E-01
TP53-Mutant-vs-TP53-NonMutant
2.088200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
